Evidence map›Paper›PMID 28251561›Full record

ArticleInternational journal of implant dentistry2017

Platelet-rich fibrin prepared from stored whole-blood samples.

Kazushige Isobe, Masashi Suzuki, Taisuke Watanabe, Yutaka Kitamura, Taiji Suzuki, Hideo Kawabata, Masayuki Nakamura, Toshimitsu Okudera, Hajime Okudera, Kohya Uematsu and 3 more

Open access · diamondAbstract read
In one paragraph

Article in International journal of implant dentistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Direct activation of platelets by addition of CaClInternational journal of implant dentistry · 2018
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Kazushige IsobeTokyo Plastic Dental Society, Kita-ku, Tokyo, Japan.
Masashi SuzukiTokyo Plastic Dental Society, Kita-ku, Tokyo, Japan.
Taisuke WatanabeTokyo Plastic Dental Society, Kita-ku, Tokyo, Japan.
Yutaka KitamuraTokyo Plastic Dental Society, Kita-ku, Tokyo, Japan.
Taiji SuzukiTokyo Plastic Dental Society, Kita-ku, Tokyo, Japan.
Hideo KawabataTokyo Plastic Dental Society, Kita-ku, Tokyo, Japan.
Masayuki NakamuraTokyo Plastic Dental Society, Kita-ku, Tokyo, Japan.
Toshimitsu OkuderaTokyo Plastic Dental Society, Kita-ku, Tokyo, Japan.
Hajime OkuderaTokyo Plastic Dental Society, Kita-ku, Tokyo, Japan.
Kohya UematsuDivision of Oral Implantology, Niigata University Medical and Dental Hospital, Niigata, Japan.
Koh NakataBioscience Medical Research Center, Niigata University Medical and Dental Hospital, Niigata, Japan.
Takaaki TanakaDepartment of Materials Science and Technology, Niigata University, Niigata, Japan.
Tomoyuki KawaseDivision of Oral Bioengineering, Institute of Medicine and Dentistry, Niigata University, Niigata, Japan. kawase@dent.niigata-u.ac.jp.ORCID http://orcid.org/0000-0003-4160-396X
Tokyo Dental College · JPNiigata University · JPNiigata University Medical and Dental Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn regenerative therapy, self-clotted platelet concentrates, such as platelet-rich fibrin (PRF), are generally prepared on-site and are immediately used for treatment. If blood samples or prepared clots can be preserved for several days, their clinical applicability will expand. Here, we prepared PRF from stored whole-blood samples and examined their characteristics.

methodsBlood samples were collected from non-smoking, healthy male donors (aged 27-67 years, N = 6), and PRF clots were prepared immediately or after storage for 1-2 days. Fibrin fiber was examined by scanning electron microscopy. Bioactivity was evaluated by means of a bioassay system involving human periosteal cells, whereas PDGF-BB concentrations were determined by an enzyme-linked immunosorbent assay.

resultsAddition of optimal amounts of a 10% CaCl

conclusionsQuality of PRF clots prepared from stored whole-blood samples is not reduced significantly and can be ensured for use in regenerative therapy. Therefore, the proposed method enables a more flexible treatment schedule and choice of a more suitable platelet concentrate immediately before treatment, not after blood collection.

Indexed as

AnticoagulantCalcium chlorideCoagulationFibrin fiberPlatelet-rich fibrin

Identifiers

PMID28251561
PMCPMC5332319
OpenAlexW2593108738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.